Vina Churdboonchart
Corporate Officer/Principal bei Mahidol University
Profil
Dr. Vina Churdboonchart is President at Trinity Medical Group, Inc. and a Member at Mahidol University.
Aktive Positionen von Vina Churdboonchart
| Unternehmen | Position | Beginn |
|---|---|---|
| Mahidol University | Corporate Officer/Principal | 25.02.2010 |
Ehemalige bekannte Positionen von Vina Churdboonchart
| Unternehmen | Position | Ende |
|---|---|---|
Trinity Medical Group, Inc.
 Trinity Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Trinity Medical Group, Inc. markets HIV-Immunogen also known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus. REMUNE is an immune-based therapy consisting of whole inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology. The company was founded on September 28, 1998 and is headquartered in Las Vegas, NV. | Gründer | 25.02.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Trinity Medical Group, Inc.
Trinity Medical Group, Inc. Miscellaneous Commercial ServicesCommercial Services Trinity Medical Group, Inc. markets HIV-Immunogen also known as REMUNE, a patented therapeutic vaccine treatment, designed to induce specific T cell responses in people infected with the Human Immunodeficiency Virus. REMUNE is an immune-based therapy consisting of whole inactivated HIV-1 virus depleted of its gp120 coat protein based on Dr. Jonas Salk's vaccine technology. The company was founded on September 28, 1998 and is headquartered in Las Vegas, NV. | Commercial Services |
